Posted by admin on Oct 19th, 2009 | 0 comments
According to a recent study, a new targeted therapy has successfully cured acute myeloid leukemia or AML. Till recent times, this disease was considered to be resistant towards all possible treatments.
The therapy was initially conducted on mice. The researchers created an antibody called 7G3 and placed it into the mice. This antibody identifies and binds CD123. CD123 in turn is expressed at high...